Loss-of-function genetic screens with pooled sgRNA and shRNA libraries aid in discovery / prioritization of drug targets, understanding of disease progression and gene-disease associations, analysis of signal transduction pathways, characterization of the mechanisms for compounds, uncovering of synergistic gene interactions, and identification of markers of drug resistance and sensitivity. This webinar presents a comparison of loss-of-function genetic screens performed with CRISPR versus RNAi technology.
Recommended Videos
RNAi, a Promising Potential New Class of Medicines
VideoRNAi is a novel and innovative approach to specifically target and silence any gene involved in the cause or pathway of disease.
WATCH NOWThaw, Plate, Incubate: Cryopreserved Hepatocyte Thawing and Plating Instructions
VideoThis video guide provides step-by-step instructions on the proper way to thaw, plate, and incubate cryopreserved hepatocytes for optimal results.
WATCH NOWIntroducing the New TSQ Altis and TSQ Quantis Triple Quadrupole MS
VideoThe new generation Thermo Scientific™ TSQ Altis™ and TSQ Quantis™ Triple Quadrupole Mass Spectrometers enable every user to achieve supreme confidence in targeted quantitation for every molecule type, in every matrix.
WATCH NOWComments | 0 ADD COMMENT
Like what you just watched? You can find similar content on the communities below.
Drug Discovery Genomics Research Proteomics & MetabolomicsTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
World Vaccine & Immunotherapy Congress West Coast
Nov 30 - Dec 01, 2017
San Diego, California, United States
Read more
Login
You must be logged in to post a comment.